Deutsche Bank AG Reiterates CHF 258 Price Target for Roche Holding Ltd. (ROG)
Roche Holding Ltd. (VTX:ROG) received a CHF 258 price objective from investment analysts at Deutsche Bank AG in a report issued on Wednesday. The firm currently has a “neutral” rating on the healthcare company’s stock.
A number of other analysts have also issued reports on the company. Goldman Sachs Group, Inc. (The) set a CHF 335 price objective on Roche Holding and gave the company a “buy” rating in a research note on Thursday, August 24th. Kepler Capital Markets set a CHF 230 target price on Roche Holding and gave the stock a “neutral” rating in a research note on Monday, September 11th. J P Morgan Chase & Co restated a “buy” rating on shares of Roche Holding in a research note on Monday, September 11th. Citigroup Inc. reaffirmed a “buy” rating on shares of Roche Holding in a report on Wednesday, July 5th. Finally, Sanford C. Bernstein set a CHF 284 target price on Roche Holding and gave the company a “buy” rating in a report on Thursday, July 27th. Two equities research analysts have rated the stock with a sell rating, six have given a hold rating and eight have assigned a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average target price of CHF 267.73.
Roche Holding (VTX:ROG) opened at 249.10 on Wednesday. The firm has a market cap of CHK 212.55 billion and a P/E ratio of 22.12. Roche Holding has a 1-year low of CHK 218.30 and a 1-year high of CHK 273.00. The company has a 50-day moving average price of CHK 244.22 and a 200-day moving average price of CHK 251.61.
TRADEMARK VIOLATION WARNING: This piece of content was first published by American Banking News and is owned by of American Banking News. If you are viewing this piece of content on another site, it was stolen and reposted in violation of US and international copyright law. The original version of this piece of content can be viewed at https://www.americanbankingnews.com/2017/10/04/deutsche-bank-ag-reiterates-chf-258-price-target-for-roche-holding-ltd-rog.html.
Roche Holding Company Profile
Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.
Receive News & Ratings for Roche Holding Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.